Wallroth Donald E. 4/A
4/A · Molecular Insight Pharmaceuticals, Inc. · Filed May 14, 2009
Insider Transaction Report
Form 4/AAmended
Wallroth Donald E.
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2009-05-12+90,000→ 90,000 totalExercise: $3.93Exp: 2019-05-12→ Common Stock (90,000 underlying)
Footnotes (2)
- [F1]This amendment to Form 4 is being filed to correct the vesting schedule for 60,000 option shares reported on Form 4 so that all 90,000 option shares granted on May 12, 2009 by the Issuer to the reporting person shall vest over two years.
- [F2]This option vests and becomes exercisable in two equal annual installments of 45,000 shares each on May 12, 2010 and May 12, 2011, respectively.